Nitto Avecia
Evan Nason is a seasoned professional with a background in quality control and analytical chemistry. Currently serving as a Senior Quality Control Analyst at Nitto Avecia since October 2021, Evan has progressively advanced through various roles within the company, starting from Quality Control Analyst I. Prior experience includes working as an Analytical Chemist at Alpha Analytical, where responsibilities involved performing wet chemistry analyses for various compounds. Early career roles span security supervision, labor, delivery services, and event staffing, reflecting diverse skills and adaptability. Evan holds a Bachelor of Science in Environmental Science from the University of Massachusetts Amherst, completed in 2020.
Nitto Avecia
1 followers
Oligonucleotides are giving rise to a new generation of therapeutics—and Nitto Avecia is helping lead the way. With more than 25 years’ experience in oligonucleotide development and production, we are the partner of choice for pharmaceutical innovators creating new drugs with the power to transform treatment for a wide range of diseases. In partnership with Nitto Avecia Pharma Services, Nitto Avecia is the first CMO that offers a comprehensive, end-to-end oligonucleotide solution. This offers the advantage of a single, expert partner handling the entire process—from drug substance through drug product manufacturing—with flexible solutions and consistent reliability and quality.